1. Priest JR, Hedlund BE. Cyanosis in an infant caused by a fetal m-hemoglobin. Northwest Pediatric Society Annual Meeting 1988.
2. Bonilla MA, Gilmore B, Gillio AP, Ruggiero M, Abboud M, Brochstein JA, Gabrilove J, Vincent M, Priest J, O’Reilly RJ. In vivo administration of recombinant human G-CSF corrects the neutropenia associated with Schwachman-Diamond syndrome. American Society of Hematology Annual Meeting 1989.
3. Shannon KM, Watterson J, Johnson P, O’Connell P, Lange B, Shah N, Steinherz P, Kan YW, Priest JR. Monosomy 7 myeloproliferative disease in children with neurofibromatosis Type I (NF-1). American Society of Hematology Annual Meeting 1991.
4. Jaszcz W, Moertel C, Simonton SA, Chartrand SL, Cich J, Watterson J, Neglia J. Flow cytometric DNA ploidy analysis of medulloblastoma in children and young adults. International Academy of Pathology Annual Meeting 1992.
5. Finlay J, Wasserman R, Priest J, Moertel C, Willoughby M, Provisor A, Jakacki R, Garvin J, Meek R, Halpern S, Orchard P, Ramsey N, Wollner N. A pilot study of brief intensive chemotherapy for children with high-risk small non-cleaved cell lymphoma (SNCCL) and acute B-cell leukemia (B-ALL). American Society of Pediatric Hematology/Oncology Annual Meeting 1992.
6. Frost M, Moertel C, Watterson J. Myoclonic seizures in a child treated with ifosfamide. Child Neurology Society Annual Meeting 1992.
7. Parisi JE, Scheithauer BW, Priest JR, Okazaki H, Komori T. Desmoplastic infantile ganglioglioma (DIG): a form of gangliogliomatosis? American Society of Neuropathologists Annual Meeting 1992
8. Boyer MW, Moertel C, Priest JR, Woods WG. Intracavitary cisplatin in the pediatric oncology patient. American Society of Pediatric Hematology/Oncology Annual Meeting 1992.
9. Tomlinson FH, Scheithauer BW, Moertel C, Sebo T, Harrison J, O’Neill B, Mason B, Katzmann J, Jaszcz W, Meyer FB. Prognostic factors in medulloblastoma. American Association of Neuropathologists Annual Meeting 1993.
11. Moertel C, Priest J, Toogood I, Nieder M, Frierdich S. Excessive spinal cord and CNS toxicity in Burkitt leukemia/lymphoma therapy in childhood. American Society of Pediatric Hematology/Oncology Annual Meeting 1993.
12. Priest J, Watterson J, Dehner L, Friend S, McIntyre J, Strong L, Hansen M, Byrd B, Feusner J, Amylon M, Bostrom B, Langston C, Pappo A. Childhood pleuropulmonary blastoma (PPB) as a unique marker for familial childhood neoplasms. American Society of Clinical Oncology Annual Meeting 1994.
13. Key N, Heisel M, Boelsen R, Chace B, Osip J, Johnson V, Moertel C. Immune tolerance induction (ITI) in hemophilia: 8 years experience at one treatment center. National Hemophilia Foundation Annual Meeting 1994.
14. Coffin CM, Watterson J, Priest J, Dehner LP. Inflammatory myofibroblastic tumor: a clinicopathologic and immunohistochemical study of 73 patients. United States And Canadian Academy of Pathology Annual Meeting 1994.
15. Manco-Johnson M, Nuss R, Key N, Moertel C, Jacobson L, Meech S. Acquired protein S deficiency, lupus anticoagulant (LA) and thrombotic risk in 5 children with varicella. American Society of Hematology Annual Meeting 1994.
16. Simonton SC, Johnson P, Priest J, Watterson J, Casey T. Acquisition of monosomy 7 following granulocyte colony stimulation factor (GCSF) administration for treatment of congenital neutropenias: report of 2 patients. Society for Pediatric Pathology Annual Meeting 1994.
17. Moertel CL, Smith C, Nelson S, Hilden J. Lack of sustained response to high dose dexamethasone therapy (Dex) in children with chronic immune-mediated thrombocytopenic purpura (ITP). American Society of Hematology Annual Meeting 1995.
18. Hilden J, Watterson J, Garr C, Telander R. “I had medullary thyroid cancer: should my children be tested?” A case of preventive oncology. Northwest Pediatric Society Annual Meeting 1995.
19. Swanson J, Moertel C, Stroncek D, Heisel M, Key NS. Serological evidence that Factor IX inhibitor in the plasma of hemophilia B patients detects Factor IX on normal red blood cells. American Society of Hematology Annual Meeting 1995.
20. McDermott MB, Manivel CM, Priest J, Watterson J, Dehner LP. Subclassification of pleuropulmonary blastoma (PPB): correlation with disease: recurrence and eventual outcome. Society for Pediatric Pathology Annual Meeting 1996.
21. Coffin CM, Dehner LP, Priest J, Watterson J, Perkins S. Extrapulmonary inflammatory myofibroblastic tumor: does Epstein-Barr virus have a pathogenetic role? United States and Canadian Academy of Pathology 1996.
22. Hilden JM, Moertel CL, Dunn ME, Scheithauer BW, Longee DC, Friedman HS. Treatment of CNS atypical teratoid/rhabdoid tumor in childhood. 7th International Symposium of Pediatric Neuro-Oncology 1996.
23. Slomiany D, Moertel C, Schmidt K, Ketchum D, Swanson D. Catheter-directed continuous infusion urokinase thrombolysis (CIUK) in children under 19 years. The American Society of Pediatric Hematology Oncology 11th Annual Meeting 1998.
24. Moertel C, Slomiany D, Ketchum D, Heisel M, Smith C. Catheter-directed continuous infusion urokinase for treatment of pediatric thrombosis. Annual Meeting of the American Society of Hematology 1998.
25. Dahlheimer T, Schaefers V, Sommer K, Watterson J, Carlson-Green B. Implementation of a Proactive Educational Intervention Program. Annual Meeting of the Association of Pediatric Oncology Nurses 1999.
26. Hilden JM, Biegel J, Rorke L, Watterson J, Walter A. Registry for central nervous system (CNS) atypical teratoid tumor/rhabdoid tumor (ATT/RT): treatment and outcome in 18 cases. International symposium on pediatric neuro-oncology 2000.
27. Carlson-Green B, Watterson J, Oliver J. Proactive Educational Intervention Program (PEIP): description and experience with pediatric oncology patients. Children’s Oncology Group Psycho-Oncology Meeting 2001.
28. Bendel A, Mahmoud N, Madsen L, Alshiekh M, Heisel M. The use of recombinant Factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients. International Symposium on Paediatric Neuro-Oncology 2002.
29. Bendel A, Hargens L, Moertel C, Rosen G. Sleep disturbances in children with brain brain tumors. International Symposium on Paediatric Neuro-Oncology 2002.
30. Heisel M, Mahmoud N, Madsen L, Alshiekh M, Bendel A. The use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients. Annual Meeting of the American Society of Hematology 2002.
31. Messinger Y, Allen C, Watterson J, Hakel L, Williams G, Alshiekh M. Exposure to native E. coli L-asparaginase sensitizes patients to the pegylated form of E. coli L-asparaginase. American Society of Hematology Meeting Book 2002.
32. Bostrom B, Messinger Y, Berglund C, Trompeter-Schlieman J, Hirsch B, Alshiekh M, Casey T. Expression of CD 22 and CD 52 in pediatric acute lymphoblastic leukemia. American Society of Hematology Meeting Book 2002.
